Healthcare activities | NĀ =ā5157 | NĀ =ā10,883 |
---|---|---|
BC patients with high cardiotoxicity risk (%) a | BC patients with lower cardiotoxicity risk (%) a | |
Laboratory tests | ||
āTroponin I/T | 5.1 | 3.8 |
āBNP/ NT-proBNP | 5.8 | 2.9 |
Imaging | ||
āCMR | 0.7 | 0.2 |
āEchocardiography | 17.7 | 8.7 |
āCT with coronary calcium score | 0.4 | 0.2 |
āCardiac nuclear imaging | 27.7 | 1.2 |
āāMUGA scan | 26.5 | 0.4 |
Diagnostic tests | ||
āECG | 52.0 | 26.5 |
āExercise stress test | 3.7 | 4.1 |
ā24-h Holter monitoring | 2.4 | 2.1 |
āAngiography | 0.4 | 0.5 |
āāWith FFR | 0.1 | 0.1 |
āāWith IVUS | 0.02 | 0 |
āReveal | 0.02 | 0.06 |